Fund moves

Medtronic (MDT): Fort Washington Investment Advisors Inc added to its stake +44K shares

Fort Washington Investment Advisors Inc added to its stake in Medtronic, per its Q4 2025 13F.

2.61M
Shares reported · +44K vs prior quarter
1.3%
Disclosed portfolio weight
$250M
Reported value
Holdings as of
Dec 31, 2025
Filed
Jan 13, 2026

What stands out in this filing

  • 2,561,597 shares in Q3 2025, 2,605,343 now (+1.7% in share count).
  • Reported at $250M, 1.33% of the portfolio value in this 13F filing.
  • 63 other tracked managers reported the same kind of change for Q4 2025.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 5, 2025CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
  2. Nov 13, 2025CongressDisclosed partial sale of MDT — reported range $1,001 - $15,000
  3. Nov 18, 2025Company filing · Form 8-K · ResultsReported its results
  4. Nov 19, 2025Insider · 1 personInsiders: 7 sales (~$3.1M)
  5. Dec 3, 20255% stakeThe Vanguard Group reported a passive stake (13G) of 10.2%
  6. Dec 18, 2025CongressDisclosed sale of MDT — reported range $1,001 - $15,000

What came next

  1. Feb 5, 2026Layoff notice · 18000 Devonshire Street Northridge CA 91325Layoff notice filed in CA: 81 employees
  2. Feb 17, 2026Company filing · Form 8-K · ResultsReported its results
  3. Feb 19, 2026Insider · 1 personInsiders: 5 sales (~$5.1M)
  4. Mar 20, 2026CongressDisclosed sale of MDT — reported range $15,001 - $50,000
  5. Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  6. Apr 21, 2026FDAFDA device clearance: CD Horizon™ ModuLeX™ Fenestrated Screw Set; CD Horizon™ ModuLeX™ Spinal System
  7. Apr 21, 2026FDARecall: Medtronic DLP Retrograde Cannula Manual-Inflate Silicone Body 15FR, Model 94725; Cardiopulmonary bypass vascular catheter
  8. Apr 23, 2026FDAFDA device clearance: Elongated One-Piece Arterial (EOPA) 3D™ Arterial Cannulae
  9. Apr 23, 2026FDAFDA device clearance: Liberant™ RX Aspiration Catheter
  10. Apr 23, 2026FDARecall: Covidien Mon-a-Therm general purpose temperature probe size: 9 Fr REF: 90050
  11. Apr 23, 2026FDARecall: Covidien Shiley Disposable Decannulation Plug REF DDCP UDI-DI code: 10884522004060 Product Codes that include the Covidien Shiley Disposable Decannulation Plug…
  12. Apr 23, 2026FDARecall: Covidien Mon-a-Therm General Purpose Temperature Probe REF: 90044
  13. Apr 23, 2026FDARecall: Covidien Mon-a-Therm Esophageal Stethoscope with Temperature Sensor 400TM REF: 90042
  14. Apr 28, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
  15. May 1, 2026FDAFDA device clearance: Capnostream™35 Portable Respiratory Monitor (PM35MN)
  16. May 12, 2026FDARecall: Octopus Evolution AS Tissue Stabilizer, Model TS2500
  17. May 12, 2026FDARecall: Octopus 4 Tissue Stabilizer, Model 29400
  18. May 12, 2026FDARecall: Octopus Evolution Tissue Stabilizer, Model TS2000
  19. May 13, 2026FDARecall: Medtronic 1x4 Pocket Adaptor Kit for Deep Brain Stimulation, Model 64001; Stimulator, electrical, implanted, for parkinsonian tremor
  20. May 13, 2026FDARecall: Medtronic 2x4 Pocket Adaptor Kit for Deep Brain Stimulation, Model 64002; Stimulator, electrical, implanted, for parkinsonian tremor
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Medtronic

For Medtronic, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MDT page.

How this filing works

Explore the data

Common questions

What does this filing report about Medtronic (MDT) stock?

Fort Washington Investment Advisors Inc added to its stake in Medtronic, per its Q4 2025 13F. Now 2.61M shares, $250M reported value, 1.3% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Dec 31, 2025. Filed: Jan 13, 2026.

What stands out in this filing?

2,561,597 shares in Q3 2025, 2,605,343 now (+1.7% in share count). Reported at $250M, 1.33% of the portfolio value in this 13F filing. 63 other tracked managers reported the same kind of change for Q4 2025.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Medtronic recently?

For Medtronic, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the MDT page.

Does this mean MDT stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Medtronic

Everything OQRO holds on this company is on its MDT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data